Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects

International Journal of Clinical Practice

Volumn 61, Issue 4, 2007, Pages 545-551

  Milionis, H J ^a   Kostapanos, M S ^a   Liberopoulos, E N ^a   Goudevenos, J ^a   Athyros, V G ^b   Mikhailidis, D P ^c   Elisaf, M S ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC SYNDROME X; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PROGNOSIS; RISK FACTORS; STROKE;

EID: 33947383676     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01269.x     Document Type: Article

References (23)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28.
2. Liberopoulos EN, Mikhailidis DP, Elisaf MS. Diagnosis and management of the metabolic syndrome in obesity. Obes Rev 2005; 6: 283-96.
3. Wilson PWF, D'Agostino RB, Parise H et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005; 112: 3066-72.
4. Wannamethee SG, Shaper AG, Lennon L et al. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke and type 2 diabetes mellitus. Arch Intern Med 2005; 165: 2644-50.
5. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004; 173: 309-14.
6. McNeill AM, Rosamond WD, Girman CJ et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385-90.
7. Athyros VG, Bouloukos VI, Pehlivanidis AN et al. MetS-Greece Collaborative Group. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes Obes Metab 2005; 7: 397-405.
8. Kurl S, Laukkanen J, Niskanen L et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006; 37: 806-11.
9. Scuteri A, Najjar SS, Morrell CH et al. Cardiovascular Health Study. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 2005; 28: 882-7.
10. Najarian RM, Sullivan LM, Kannel WB et al. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke; the Framingham Offspring Study. Arch Intern Med 2006; 166: 106-11.
11. Maggi S, Noale M, Gallina P et al. ILSA Working Group. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci 2006; 61: 505-10.
12. Milionis HJ, Rizos EC, Goudevenos J et al. Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke 2005; 36: 1372-6.
13. He Y, Jiang B, Wang J et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006; 47: 1588-94.
14. Grundy SM, Cleeman JI, Daniels SR et al. American Heart Association. National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52.
15. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-62.
16. Sone H, Tanaka S, Ishibashi S et al. for the Japan Diabetes Complications Study (JDCS) group. The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions; additional analysis from the Japan Diabetes Complications Study. Diabetes Care 2006; 29: 145-7.
17. Adams HPJ, Bendixen BH, Kappelle LJ et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993; 24: 35-41.
18. Athyros VG, Ganotakis ES, Elisaf M et al. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 2005; 21: 1157-9.
19. Daskalopoulou SS, Mikhailidis DP, Elisaf M. Prevention and treatment of the metabolic syndrome. Angiology 2004; 55: 589-612.
20. Liberopoulos EN, Tsouli S, Mikhailidis DP et al. Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures. Curr Drug Targets 2006; 7: 211-28.
21. Hanley AJG, Karter AJ, Williams K et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome; the Insulin Resistance Atherosclerosis Study. Circulation 2005; 112: 3713-21.
22. Kahn R, Buse J, Ferrannini E et al. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289-304.
23. Liberopoulos EN, Elisaf MS. Diagnosis of the metabolic syndrome: which definition should we use? Hellenic J Cardiol 2005; 46: 258-62.